S. Naruhn

Inverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion

M. Scharfe, F. Finkernagel, M. Jarek, 2012, Oncogene.

High-Affinity Peroxisome Proliferator-Activated Receptor β/δ-Specific Ligands with Pure Antagonistic or Inverse Agonistic Properties

Veronika F. S. Pape, G. Klebe, R. Müller, 2011, Molecular Pharmacology.

(Z)-2-(2-bromophenyl)-3-{[4-(1-methyl-piperazine)amino]phenyl}acrylonitrile (DG172): an orally bioavailable PPARβ/δ-selective ligand with inverse agonistic properties.

R. Müller, W. Meissner, W. Diederich, 2012, Journal of medicinal chemistry.

Cellular and Pharmacological Selectivity of the Peroxisome Proliferator-Activated Receptor-β/δ Antagonist GSK3787

S. Amin, J. Peters, R. Müller, 2010, Molecular Pharmacology.

15-Hydroxyeicosatetraenoic Acid Is a Preferential Peroxisome Proliferator-Activated Receptor β/δ Agonist

Wolfgang Meissner, Till Adhikary, Kerstin Kaddatz, 2010, Molecular Pharmacology.